63
Growth Score in past quarter
pts
Heat Score 63 in past quarter
14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
PoC Capital invests in life science companies, primarily those in the clinical development stage.
- Daron Evans: Managing DirectorPast Role: Specialty Renal Products(SRP), Chief Executive Officer & President
- Mike Loftus: Director
About the Company
PoC Capital seeks to invest in small, public life science companies whose product candidates have the opportunity to improve patient well-being. Strong management teams, clear mechanisms of action, and well-validated product development plans are key components of our investment thesis. PoC Capital specifically provides funding for companies to
execute proof-of-concept clinical trials, which serve to unlock the value of development-stage assets through safety and efficacy validation.